View drug registration information details.
Items | Registration information |
ID | 566 |
No | 566 |
Brand Name | NEBILET TABLET |
Ingredients | NEBIVOLOL HYDROCHLORIDE 5.45 MG EQ.TO NEBIVOLOL 5 MG |
Dosage Form | TABLET |
Primary Packaging | PVC/AL -BLISTER |
Storage | STORE BELOW 25 C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 14, 28, 30 TABLETS |
Dispensing Category | PRESCRIPTION |
ATC Classification | C07AB12 |
Pharmaceutical Class | ANTIHYPERTENSIVE |
Indications | TREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF STABLE MILD AND MODERATE CHRONIC HEART FAILURE IN ADDITION TO STANDARD THERAPIES IN ELDERLY PATIENTS>70 YEARS |
Contraindications | HYPERSENSITIVITY, LIVER INSUFFICIENCY OR LIVER FUNCTION IMPAIRMENT, ACUTE HEART FAILURE, CARDIOGENIC SHOCK OR EPISODE OF HEART FAILURE DECOMPENSATION REQUIRING I.V. INOTROPIC THERAPY |
Side Effects | HEADACHE, DIZZINESS, PARAESTHESIA, DYSPNOEA, CONSTIPATION, NAUSEA, DIARRHEA, TIRENESS, OEDEMA |
Unit Price | |
EDL |
No |
Description | WHITE, ROUND, CROSS-SCORED TABLET. |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | BERLIN-CHEMIE AG |
Country | GERMANY |
Import Registration No | 36893.00.00 |
Import Registration Date | 1996-06-20 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-12-03 |
FDD Registration No | 03 I 5438/23 |
FDD Registration Date | 2023-03-31 |
Expiry Date | 2026-03-30 |
Back to drug list
|